GE Seeking FDA, EU Approval for CodeLink P450; Protein Array in R&D | GenomeWeb

VANCOUVER, BC -- GE Healthcare plans to submit its CodeLink P450 SNP bioarray platform for market clearance for use in in vitro diagnostics in the United States and Europe, a GE official said here last week at the World Microarray Congress.

The official also said the company is in the process of developing its first ever protein array.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.